Guideline Affirms Role of Biomarkers in Crohn's Disease
'Use of biomarkers is no longer considered experimental and should be an integral part of IBD care and monitoring.'
Stay updated with breaking news from Practice Guidelines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
'Use of biomarkers is no longer considered experimental and should be an integral part of IBD care and monitoring.'
/PRNewswire/ -- Today the Latin American and Caribbean Society of Medical Oncology (SLACOM) and National Comprehensive Cancer Network® (NCCN®) host the Latin...
Today the Latin American and Caribbean Society of Medical Oncology and National Comprehensive Cancer Network host the Latin American Regional Breast Cancer Summit: Advocating and Implementing Guideline-Concordant Cancer Care for Patients.
In crafting a patient-centered regimen, the convergence of expertise from physicians and pharmacists, paired with the values and preferences of patients, becomes paramount.
/PRNewswire/ -- Medical oncologist Lucio N. Gordan MD, president and managing physician of Florida Cancer Specialists & Research Institute, LLC (FCS), is lead...